Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk
2005

HHV8 and Multiple Myeloma Risk

Sample size: 1960 publication Evidence: high

Author Information

Author(s): Tedeschi R, Luostarinen T, De Paoli P, Gislefoss R E, Tenkanen L, Virtamo J, Koskela P, Hallmans G, Lehtinen M, Dillner J

Primary Institution: Centro di Riferimento Oncologico, IRCCS, Italy

Hypothesis

Is there an association between human herpesvirus 8 (HHV8) and the risk of multiple myeloma (MM)?

Conclusion

The data indicate that HHV8 infection is not associated with multiple myeloma.

Supporting Evidence

  • HHV8 seroprevalences among cases and controls were similar (12% and 15%, respectively).
  • HHV8 seropositivity did not associate with the risk of MM.
  • Similar risks were seen when analysis was restricted to case–control sets with at least 2 years lag before diagnosis.

Takeaway

The study looked at whether a virus called HHV8 causes a type of cancer called multiple myeloma, and it found that it does not.

Methodology

The study linked five large serum banks in the Nordic countries with cancer registries to identify cases of MM and matched controls.

Potential Biases

The study design minimizes epidemiological sources of bias, but there may still be risks related to the measurement of serological responses.

Limitations

The study may have limitations related to the potential for measurement biases in serological assays due to high levels of myeloma proteins in patients.

Participant Demographics

The study included 329 cases of MM and 1631 matched controls based on age and gender.

Statistical Information

P-Value

0.004

Confidence Interval

0.5–1.1

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602751

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication